The present study demonstrated the expression of intercellular adhesion molecule-i (ICAM-1) and vascular cell adhesion molecule-I (VCAM-1), the 
Diabetic epiretinal membranes are the main pathological changes of proliferative diabetic retinopathy (PDR) which may cause severe complications resulting in blindness. The mechanism of the development of diabetic epiretinal membranes is still unknown. Studies of histopathology and immunohistochemistry demonstrated that these membranes consist of different types of cells such as fibroblasts, glial cells, retinal pigment epithelial cells, and macrophages, and different types of extracellular matrixes."l On the other hand, some other studies demonstrated the presence of immune cells, immunoglobulins, and complement proteins in the epiretinal membranes implicating the involvement of the immune system.7`9 The participating cells seem to grow in concert, mutually influencing tissue proliferation. 0 In multicellular tissues such as epiretinal membranes cell-cell interactions may be a major factor in the control of cell migration, cell recognition and adhesion, cell differentiation, and proliferation. Intercellular adhesion molecule-i (ICAM-1) and vascular cell adhesion molecule-I (VCAM-1) are two ofthe cell adhesion molecules (CAMs) which are considered to be important for the initiation of some adhesion dependent immune responses." 2 ICAM-1 and VCAM-1 have been known to participate in the process of lymphocyte adherence to the vascular endothelial cells, which is important for the entry of lymphocytes into the sites of immune responses or inflammation. 314 Histopathological studies have also shown that the new vessels are one of the components of the epiretinal membranes of PDR. 23 Most of the new vessels, some of which are fenestrated, in epiretinal membranes are associated with a thickened, multilaminated basement membrane.31" Although immunohistochemical studies have shown the expression of MHC class II antigens on the vascular endothelial cells and the deposits of immunoglobulins and complement factors in the vascular wall,8 the proliferative activity and the activation of the vascular endothelial cells in diabetic epiretinal membranes have not yet been studied in detail. In the present study, we investigated, using immunohistochemical techniques, the extent of the neovascularisation with a monoclonal antibody against proliferating vascular endothelial cells and the expression of the intercellular adhesion molecule-I (ICAM-1) and the vascular cell adhesion molecule-I (VCAM-1) which are two of the markers for endothelium activation in diabetic epiretinal membranes.
Materials and methods

COLLECTION AND PROCESSING OF EPIRETINAL MEMBRANES
In this study, a total of 40 diabetic epiretinal membranes were studied. They were surgically excised from 40 patients with proliferative diabetic retinopathy during pars plana vitrectomy. All except one case had undergone panretinal argon laser photocoagulation before vitrectomy. The epiretinal membranes (as much as possible) were carefully peeled off the retinal surface, excised with microscissors and taken out ofthe vitreous cavity by a microforceps. Immediately after excision, the membrane specimens were placed in Ringer's solution or balanced salt solution (BSS) and maintained at 4°C. They were then embedded in OCT (Tissue-tek) compound and snap frozen in isopentane (2-methylbutane) chilled previously with liquid nitrogen. Cryosections (6 [tm) were cut and mounted on 01% poly-l-lysin precoated slides and air dried at room temperature for 4 hours. The slides were then fixed in cold acetone for 10 minutes and wrapped, stored at -40°C until use.
After their use for the immunohistochemical study, the rest of the specimens were fixed in 10% formaldehyde solution for 6 to 24 hours. They were then processed for routine haematoxylin and eosin staining for the assessment of cellularity and cell morphology.
MONOCLONAL ANTIBODIES
A mouse monoclonal anti-human proliferating endothelial cell antibody EN 7/44 (Dianova, Germany) was used to evaluate the extent of the neovascularisation in the membranes. EN Figs 1 A, B) . The cell nuclei were counterstained in blue. Unfortunately, many of them were lost during processing. The proliferation marker was detected by EN (Figs 3 A, B) . In some cases, ICAM-1 and VCAM-1 were distributed diffusely in the intercellular spaces. The intensity of ICAM-1 and VCAM-1 expression varied from case to case and seemed to be correlated with the severity ofpathological changes (epiretinal membrane formation) of PDR, but not with the age and sex of the patients. Generally, the expression ofICAM-1 in the membrane tissues was stronger than that of VCAM-1. In addition, ICAM-l and VCAM-1 were also expressed on the endothelial cells of the vessels in the membranes (see below). Histologically, the membranes positive for ICAM-1 and VCAM-1 were relatively rich in cells and new vessels. Conversely, the membrane specimens (four cases) negative for both ICAM-1 and VCAM-l were rather thin, had less cellular components, and had fewer neovascularisations. The cellularity of the epiretinal membranes tested and a correlation with ICAM-1 and VCAM-1 expression are shown in Table 3 .
NEOVASCULARISATION IN PDR EPIRETINAL MEMBRANES
In the present study, 26 ICAM-1 and VCAM-1, as counter receptors for lymphocyte LFA-1 and VLA-4, provide dynamic position specific information to guide lymphocyte localisation at the site of immune responses. It has also been shown that the interactions between antigen presenting cells (macrophages/monocytes, etc) and lymphocytes need the involvement of ICAM-1 to generate immune responses and later on the interactions of T cell to T cell and also T cell to B cell.' 12 30 In the normal situation, ICAM-1 can be expressed on both haematopoietic cells such as macrophages/monocytes, activated T lymphocytes, and germinal centre dendritic cells in tonsils and lymph nodes, and non-haematopoietic cells such as vascular endothelial cells, thymic epithelial cells, and fibroblasts. However, the basal expression on non-haematopoietic cells is low.'9 ICAM-1 is very weakly expressed on resting endothelial cells, but it can be rapidly and markedly increased Neovascularisation is one of the main pathological changes of proliferative diabetic retinopathy and may cause severe complications in patients. From previous reports we know very little about the significance of the neovascularisation, especially the vascular endothelial cells, in the development of PDR membranes. Here for the first time we demonstrate the extent of proliferation of the newly formed vessels and the activation of the vascular endothelial cells by detecting the expression of cell adhesion molecules (ICAM-1 and VCAM-1) on the endothelial cells in about 80% of the neovascularised epiretinal membranes ofPDR. Interestingly, almost all of the vascular endothelial cells in the proliferating stage in the membranes were also in an activated state, although only a portion of the vessels were at the proliferating and activated stage. This provides strong evidence for the interaction of lymphocytes and endothelial cells, which has been considered to be the first critical step for lymphocyte migration into tissue and initiating an immune response, wherein ICAM-1 and VCAM-1 play the key role in these interactions. 132939 
